Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colon Tumor, Malignant”

2,404 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,404 results

Testing effectiveness (Phase 2)Study completedNCT00080951
What this trial is testing

Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 14
Not applicableUnknownNCT04147481
What this trial is testing

Effects of Abdominal Nerve Block on Postoperative Recovery in Patients Undergoing Gastrointestinal Surgery

Who this might be right for
Colon CancerRectal CancerGastric Cancer
Yi Liu 200
Not applicableEnded earlyNCT00003365
What this trial is testing

Sulindac and Plant Compounds in Preventing Colon Cancer

Who this might be right for
Colorectal Cancer
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Early research (Phase 1)Study completedNCT05396300
What this trial is testing

A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerEsophageal CancerStomach Cancer+3 more
Weijia Fang, MD 43
Very early researchEnded earlyNCT02724202
What this trial is testing

Curcumin in Combination With 5FU for Colon Cancer

Who this might be right for
Metastatic Colon Cancer
Baylor Research Institute 15
Testing effectiveness (Phase 2)Study completedNCT00333502
What this trial is testing

Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors

Who this might be right for
CancerSolid Tumor
NewLink Genetics Corporation 62
Early research (Phase 1)Ended earlyNCT02784795
What this trial is testing

LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerColon Cancer+2 more
Eli Lilly and Company 94
Not applicableStudy completedNCT05266300
What this trial is testing

Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.

Who this might be right for
Adverse Drug EventColon CancerBreast Cancer+5 more
University of Southern Denmark 722
Early research (Phase 1)Study completedNCT00054912
What this trial is testing

An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer

Who this might be right for
Colonic NeoplasmsColorectal Neoplasms
Epimmune 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT03255434
What this trial is testing

LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy

Who this might be right for
Stage III Colon Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 160
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)UnknownNCT05732493
What this trial is testing

Short-course Radiotherapy Combined With Chemotherapy and Pd-1 Inhibitor for Locally Advanced Colon Cancer(TORCH-C)

Who this might be right for
Locally Advanced Colon Cancer
Fudan University 120
Testing effectiveness (Phase 2)Study completedNCT03037385
What this trial is testing

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more
Hoffmann-La Roche 590
Not applicableUnknownNCT01527409
What this trial is testing

The Efficacy of Health Partnership Program for Cancer Patients

Who this might be right for
Breast CancerColon CancerGastric Cancer+1 more
National Cancer Center, Korea 248
Not applicableStudy completedNCT06323421
What this trial is testing

Targeting Chronic Stress for Reducing Risk Factors for Colorectal Cancer

Who this might be right for
MindfulnessColon CancerFemales
University of Illinois at Chicago 24
Very early researchWithdrawnNCT02774512
What this trial is testing

Predictive Biomarkers of Biological Activity and Efficacy of Nilotinib on ZAK Target in Non-metastatic Colon Cancer

Who this might be right for
Colon Cancer
Institut Bergonié
Not applicableUnknownNCT01801852
What this trial is testing

Autologous Natural Killer T Cells Infusion for the Treatment of Cancer

Who this might be right for
Breast CancerGliomaHepatocellular Cancer+4 more
Chinese PLA General Hospital 300
Early research (Phase 1)Ended earlyNCT00072098
What this trial is testing

Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Max Sung 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT05185947
What this trial is testing

Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer

Who this might be right for
Gynecologic CancerGynecologic NeoplasmsPeritoneal Carcinomatosis+7 more
National Cancer Institute (NCI) 19
Load More Results